| MeSH term | MeSH ID | Detail |
|---|---|---|
| Ascites | D001201 | 25 associated lipids |
| Cerebrovascular Disorders | D002561 | 25 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Pregnancy Complications | D011248 | 19 associated lipids |
| Down Syndrome | D004314 | 18 associated lipids |
| Alcoholic Intoxication | D000435 | 15 associated lipids |
| Angina, Unstable | D000789 | 14 associated lipids |
| Cerebral Hemorrhage | D002543 | 13 associated lipids |
| Respiratory Syncytial Virus Infections | D018357 | 10 associated lipids |
| Aortic Aneurysm | D001014 | 8 associated lipids |
2,3-dinor, 6-keto-PGF1alpha
2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 782 references associated with 2,3-dinor, 6-keto-PGF1alpha in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 2,3-dinor, 6-keto-PGF1alpha
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
NCBI Entrez Crosslinks
All references with 2,3-dinor, 6-keto-PGF1alpha
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Förstermann U et al. | An increase in the ratio of thromboxane A2 to prostacyclin in association with increased blood pressure in patients on cyclosporine A. | 1989 | Prostaglandins | pmid:2662262 |
| Balazy M et al. | Facile method for preparation of 2,3-dinor-6-keto PGF1 alpha, the major urinary metabolite of prostacyclin. | 1988 | Prostaglandins | pmid:3070630 |
| Falardeau P et al. | Urinary levels of 2,3-dinor-6-oxo-PGF1 alpha: a reliable index of the production of PGI2 in the spontaneously hypertensive rat. | 1985 | Prostaglandins | pmid:3890022 |
| Vesterqvist O and Gréen K | Development of a GC-MS method for quantitation of 2,3-dinor-6-keto-PGF1 alpha and determination of the urinary excretion rates in healthy humans under normal conditions and following drugs. | 1984 | Prostaglandins | pmid:6548317 |
| Rasmanis G et al. | Implications of the prognostic importance of exercise-induced thromboxane formation in survivors of an acute myocardial infarction. | 1995 | Prostaglandins | pmid:7667506 |
| Vernon WB | Prostaglandins and pancreas transplantation. | 1991 | Prostaglandins | pmid:2052737 |
| Hotter G et al. | Altered levels of tissue and urinary prostacyclin in rats subjected to pancreas transplantation. | 1991 | Prostaglandins | pmid:2052738 |
| Ylikorkala O et al. | Urinary excretion of prostacyclin and thromboxane metabolites in climacteric women: effect of estrogen-progestin replacement therapy. | 1990 | Prostaglandins | pmid:2106714 |
| Henriksson P et al. | Thromboxane synthase inhibition: "endoperoxide shunt phenomenon" does not occur in healthy humans in vivo. | 1990 | Prostaglandins | pmid:2106716 |
| Grèen K et al. | Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol). | 1989 | Prostaglandins | pmid:2664901 |